Kiniksa Pharmaceuticals International, plc Operating Lease Liability
Kiniksa Pharmaceuticals International, plc (KNSA) had Operating Lease Liability of $9.50 million as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-02-24
- 2025-12-31: Operating Lease, Liability $9.50M.
- 2024-12-31: Operating Lease, Liability $9.86M.
- 2023-09-30: Operating Lease, Liability $12.96M.
- 2023-06-30: Operating Lease, Liability $13.52M.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-12-31 | $9.50M 10-K · filed 2026-02-24 |
| 2024-12-31 | $9.86M 10-K · filed 2025-02-25 |
| 2023-09-30 | $12.96M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $13.52M 10-Q · filed 2023-08-01 |
| 2022-12-31 | $5.92M 10-K · filed 2023-03-02 |
| 2021-12-31 | $6.05M 10-K · filed 2022-02-24 |
| 2020-12-31 | $6.99M 10-K · filed 2021-02-25 |
| 2020-09-30 | $1.55M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.82M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $2.24M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $2.65M 10-K · filed 2020-03-05 |
| 2019-09-30 | $3.00M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $3.31M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $3.62M 10-Q · filed 2019-05-07 |
| 2019-01-01 | $3.92M 10-Q · filed 2019-11-05 |